Concepedia

Duncan Armstrong

DA

14

Publications

890

Citations

13

H-Index

2000

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

Novartis (United States)

AstraZeneca (Sweden)

Harvard University

Piramal (India)

Duncan Armstrong is an author at AstraZeneca (United Kingdom) specializing in medicine, physiology, and drug discovery.

ORCID

Top concepts

Publications per year

2000–2021

14

Publications

14

Characterization of the Adenosine Pharmacology of Ticagrelor Reveals Therapeutically Relevant Inhibition of Equilibrative Nucleoside Transporter 1

Duncan Armstrong, Claire Summers, Lorna Ewart et al. · Journal of Cardiovascular Pharmacology and Therapeutics · 2014 · 238 citations

Dopamine D2 Receptor Dimer Formation

Duncan Armstrong, Philip G. Strange · Journal of Biological Chemistry · 2001 · 115 citations · Full text

Agouti-Related Protein Is Posttranslationally Cleaved by Proprotein Convertase 1 to Generate Agouti-Related Protein (AGRP)83–132: Interaction between AGRP83–132 and Melanocortin Receptors Cannot Be Influenced by Syndecan-3

John W.M. Creemers, Lynn E. Pritchard, Amy Gyte et al. · Endocrinology · 2005 · 109 citations

, , +19

The activities of drug inactive ingredients on biological targets

Joshua Pottel, Duncan Armstrong, Ling Zou et al. · Science · 2020 · 86 citations · Full text

Machine learning guided association of adverse drug reactions with in vitro target-based pharmacology

Robert Ietswaart, Seda Arat, Amanda X. Chen et al. · EBioMedicine · 2020 · 71 citations · Full text

Rows per page

1–5 of 14